ENCISION, INC.

ECIA ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-220.2K $-691.8K $-323.9K $-65.6K $584.7K $-198.3K $-236.1K $335.6K
Depreciation & Amortization $81.4K $85.2K $86.9K $113.5K $89.0K $137.8K $182.1K $202.9K
Depreciation $63.7K $61.3K $59.3K $63.0K $58.9K $111.7K $154.6K $176.0K
Amortization
Stock-Based Compensation $46.0K $53.6K $51.9K $40.9K $33.4K $30.7K $37.0K $65.8K
Net Cash from Operating Activities $-54.9K $144.4K $-861.5K $-444.4K $219.9K $-229.5K $-127.2K $419.4K
Investing Activities
Capital Expenditures $54.4K $12.1K $173.3K $17.6K $30.0K $48.3K $55.2K $56.6K
Business Acquisitions
Net Cash from Investing Activities $-80.0K $-36.8K $-183.3K $-35.4K $-45.2K $-54.2K $-60.8K $-100.0K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $349.9K $-254.0K $284.1K $-44.9K $914.4K $370.5K $346.8K $-250.1K
Net Change in Cash
Free Cash Flow $-109.4K $132.3K $-1.0M $-462.0K $189.9K $-277.8K $-182.5K $362.9K
← Newer Page 1 of 2 Older →